Company / R&D per Share
Zai Lab Ltd R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.20
FY2025
5-year range
$0.20 / $1.62
FY2021-FY2025
Trend
-15.0%
vs FY2024
Sector context
#192 of 208
Health Care
What the data says
Among 208 Health Care companies, Zai Lab Ltd is in the bottom 8% for r&d per share. Declined from $0.28 to $0.20 over the past 2 years.
Based on SEC 10-K filings.
0.20 in FY2025 with a 5-year CAGR of -35.0%.
Declined from $0.28 to $0.20 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -4.2%
- 5-Year CAGR
- -35.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 208This company $0.20 Sector average $28.82
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 15.0% year-over-year.
- Ranks #192 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.20 | -15.0% |
| FY2024 | $0.24 | -12.9% |
| FY2023 | $0.28 | +18.7% |
| FY2022 | $0.23 | -85.6% |
| FY2021 | $1.62 | -8.1% |
| FY2020 | $1.76 | -20.2% |
| FY2019 | $2.21 | -3.4% |
| FY2018 | $2.29 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026